CLC bio Part of $7.8 Million EU STATegra Grant to Develop Integral Analysis Platform for Epigenetics
12/12/2012 9:24:53 AM
AARHUS, Denmark--(BUSINESS WIRE)--Today CLC bio announced the participation in the European FP7 project, STATegra, and receives 1.3 million US Dollars out of the total $7.8M project budget. STATegra aims to develop a user-friendly integral analysis platform for different omics data that is capable of providing a more efficient use of genomics technologies. As a first, this project will generate and integrate data obtained in proteomic, metabolomic and epigenomic experiments. "One of the big challenges today is going past the raw sequence data and getting to grips with the complexity of epigenetic processes - how, when, and why are certain genes switched off or expressed?" states Senior Bioinformatics Scientist at CLC bio, Dr. Michael Lappe, and continues, "By working together with leading experimental researchers and using our in-house competences in world-class software-engineering, we aim to leverage a framework which makes this extremely complex network biology understandable. Ultimately our tools will facilitate the translation of massive amounts of data into useful insights that can be applied in clinical settings."